Logo image of ALCAB.PA

CABASSE SA (ALCAB.PA) Stock Fundamental Analysis

EPA:ALCAB - Euronext Paris - Matif - FR001400DIY6 - Common Stock - Currency: EUR

1.03  -0.06 (-5.5%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ALCAB. ALCAB was compared to 35 industry peers in the Household Durables industry. ALCAB has a bad profitability rating. Also its financial health evaluation is rather negative. ALCAB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ALCAB has reported negative net income.
In the past 5 years ALCAB always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: ALCAB reported negative operating cash flow in multiple years.
ALCAB.PA Yearly Net Income VS EBIT VS OCF VS FCFALCAB.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -500K -1M -1.5M

1.2 Ratios

The Return On Assets of ALCAB (-10.70%) is worse than 91.43% of its industry peers.
Industry RankSector Rank
ROA -10.7%
ROE N/A
ROIC N/A
ROA(3y)-8.05%
ROA(5y)-9.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALCAB.PA Yearly ROA, ROE, ROICALCAB.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 200 -200 400

1.3 Margins

With an excellent Gross Margin value of 62.84%, ALCAB belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
In the last couple of years the Gross Margin of ALCAB has grown nicely.
ALCAB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.66%
GM growth 5YN/A
ALCAB.PA Yearly Profit, Operating, Gross MarginsALCAB.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

1

2. Health

2.1 Basic Checks

ALCAB has less shares outstanding than it did 1 year ago.
The debt/assets ratio for ALCAB is higher compared to a year ago.
ALCAB.PA Yearly Shares OutstandingALCAB.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 200K 400K 600K 800K 1M
ALCAB.PA Yearly Total Debt VS Total AssetsALCAB.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of 0.36, we must say that ALCAB is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.36, ALCAB is not doing good in the industry: 88.57% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.36
ROIC/WACCN/A
WACCN/A
ALCAB.PA Yearly LT Debt VS Equity VS FCFALCAB.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 2M 4M

2.3 Liquidity

ALCAB has a Current Ratio of 1.00. This is a normal value and indicates that ALCAB is financially healthy and should not expect problems in meeting its short term obligations.
ALCAB has a worse Current ratio (1.00) than 85.71% of its industry peers.
A Quick Ratio of 0.39 indicates that ALCAB may have some problems paying its short term obligations.
The Quick ratio of ALCAB (0.39) is worse than 91.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 0.39
ALCAB.PA Yearly Current Assets VS Current LiabilitesALCAB.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 72.24% over the past year.
Looking at the last year, ALCAB shows a decrease in Revenue. The Revenue has decreased by -5.39% in the last year.
Measured over the past years, ALCAB shows a small growth in Revenue. The Revenue has been growing by 4.61% on average per year.
EPS 1Y (TTM)72.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.58%
Revenue 1Y (TTM)-5.39%
Revenue growth 3Y4.61%
Revenue growth 5YN/A
Sales Q2Q%-10.03%

3.2 Future

ALCAB is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -48.16% yearly.
ALCAB is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -27.58% yearly.
EPS Next Y1249.84%
EPS Next 2Y-326.85%
EPS Next 3Y-48.16%
EPS Next 5YN/A
Revenue Next Year10.51%
Revenue Next 2Y-36.35%
Revenue Next 3Y-27.58%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALCAB.PA Yearly Revenue VS EstimatesALCAB.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
ALCAB.PA Yearly EPS VS EstimatesALCAB.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALCAB. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALCAB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALCAB.PA Price Earnings VS Forward Price EarningsALCAB.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALCAB.PA Per share dataALCAB.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

ALCAB's earnings are expected to decrease with -48.16% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-326.85%
EPS Next 3Y-48.16%

More info and screens

0

5. Dividend

5.1 Amount

ALCAB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CABASSE SA

EPA:ALCAB (3/7/2025, 7:00:00 PM)

1.03

-0.06 (-5.5%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.14M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.24
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.49
EYN/A
EPS(NY)-0.57
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.27
BVpS-0.02
TBVpS-0.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.7%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.84%
FCFM N/A
ROA(3y)-8.05%
ROA(5y)-9.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.66%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1
Quick Ratio 0.39
Altman-Z 0.36
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.58%
EPS Next Y1249.84%
EPS Next 2Y-326.85%
EPS Next 3Y-48.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.39%
Revenue growth 3Y4.61%
Revenue growth 5YN/A
Sales Q2Q%-10.03%
Revenue Next Year10.51%
Revenue Next 2Y-36.35%
Revenue Next 3Y-27.58%
Revenue Next 5YN/A
EBIT growth 1Y61.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year402.5%
EBIT Next 3Y16.72%
EBIT Next 5YN/A
FCF growth 1Y104.27%
FCF growth 3Y-43.11%
FCF growth 5YN/A
OCF growth 1Y104.27%
OCF growth 3Y-43.11%
OCF growth 5YN/A